Financhill
Buy
59

AKRO Quote, Financials, Valuation and Earnings

Last price:
$54.89
Seasonality move :
-13.54%
Day range:
$54.66 - $57.51
52-week range:
$15.32 - $58.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.23x
Volume:
2.4M
Avg. volume:
1.6M
1-year change:
147.81%
Market cap:
$3.9B
Revenue:
--
EPS (TTM):
-$3.78

AKRO Analysts' Consensus Rating

The 8 analysts providing 12-month price projections for Akero Therapeutics shares anticipate an average target of $72.18, ranging from a low estimate of $42.00 to a high estimate of $96.00. This average target implies a growth of 30.39% compared to the current stock price of $55.36.

Consensus Price Target

$72.18

Highest Price Target

$96.00

Lowest Price Target

$42.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 6 8 8

Hold 1 1 0

Sell 0 0 0
Consensus Buy Buy Buy

AKRO Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Texas Instruments Stock Overvalued?
Is Texas Instruments Stock Overvalued?

Texas Instruments Incorporated (NASDAQ:TXN) is not having an easy time…

Why Is AST SpaceMobile Stock Dropping?
Why Is AST SpaceMobile Stock Dropping?

Since Donald Trump’s pledge to send American astronauts to Mars…

1 Space Stock Up Over 150%, More To Go?
1 Space Stock Up Over 150%, More To Go?

Planet Labs combines satellite imaging and data analytics technologies to…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 104x

Alerts

Buy
69
TECX alert for Jan 31

Tectonic Therapeutic [TECX] is up 2.13% over the past day.

Buy
62
EXOD alert for Jan 31

Exodus Movement [EXOD] is down 9.24% over the past day.

Buy
62
DOGZ alert for Jan 31

Dogness (International) [DOGZ] is up 20.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock